Left Ventricular Assist Device–Related Infection: Treatment and Outcome
Clinical Infectious Diseases2005Vol. 40(8), pp. 1108–1115
Citations Over TimeTop 10% of 2005 papers
David Simón, Staci A. Fischer, Angela P. Grossman, Carol Downer, Bala Hota, Alain Heroux, Gordon M. Trenholme
Abstract
Our observations suggest that LVAD-related infection is common and may require antimicrobial therapy before, during, and after transplantation, but that it does not prevent successful transplantation. However, patients with LVAD-related infection appear to be at increased risk for invasive VREF infection, which may contribute to early mortality after transplantation.
Related Papers
- → Left ventricular assist device implantation in high risk destination therapy patients: an alternative surgical approach(2012)15 cited
- → Patients’ Perspectives on Transplantation While Undergoing Left Ventricular Assist Device Support(2017)11 cited
- → Left Ventricular Assist Device–Destination Therapy for Symptom Management in Heart Failure(2012)2 cited
- → 686: Validation of Destination Therapy Risk Score in Recipients of Left-Ventricular Assist Devices (LVAD) at a Single Center(2009)1 cited
- → 29 Quality of Life Is Higher in Destination Therapy Compared with Bridge to Transplantation Patients Following Ventricular Assist Device Implantation(2012)